Publication date: December 2026 Source: Leukemia Research, Volume 171 Author(s): Alisa Veenstra, Berdien E. Oortgiesen, Frank G.A. Jansman, Michel van Gelder, Mark-David Levin, Nic J.G.M. Veeger, Mels Hoogendoorn, on behalf of the HemoBase Population Registry Consortium
Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study. // Leukemia Research. – URL: https://www.sciencedirect.com/science/article/pii/S0145212626002055?dgcid=rss_sd_all
Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study. Leukemia Research. https://www.sciencedirect.com/science/article/pii/S0145212626002055?dgcid=rss_sd_all
“Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study.” Leukemia Research.
@article{article57351,
title = {Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study},
journal = {Leukemia Research},
url = {https://www.sciencedirect.com/science/article/pii/S0145212626002055?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment